EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:653-660. doi:10.1016/j.ejcts.2008.05.024
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thierry Carrel
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banz, Y.
Right arrow Articles by Berdat, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Banz, Y.
Right arrow Articles by Berdat, P.
Related Collections
Right arrow Extracorporeal circulation
Right arrow Myocardial protection

Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass

Yara Banza,b, Robert Riebena,b,*, Claudia Zobristc, Pascal Meierd, Sidney Shawa, Jonas Lanza, Thierry Carrelb, Pascal Berdatb

a Department of Clinical Research, University of Bern, Bern, Switzerland
b Department of Cardiovascular Surgery, University Hospital, Bern, Switzerland
c Department of Anesthesiology, University Hospital, Bern, Switzerland
d Department of Cardiology, University Hospital, Bern, Switzerland

Received 5 December 2007; received in revised form 24 April 2008; accepted 5 May 2008.

* Corresponding author. Address: University of Bern, Department of Clinical Research, Murtenstrasse 31, 3010 Bern, Switzerland. Tel.: +41 31 632 9669; fax: +41 31 632 8837. (Email: robert.rieben{at}dkf.unibe.ch).

Objective: Contact of blood with artificial surfaces and air as well as ischemia/reperfusion injury to the heart and lungs mediate systemic and local inflammation during cardiopulmonary bypass (CPB). Activation of complement and coagulation cascades leads to and accompanies endothelial cell damage. Therefore, endothelial-targeted cytoprotection with the complement inhibitor and endothelial protectant dextran sulfate (DXS, MW 5000) may attenuate CBP-associated myocardial and pulmonary injury. Methods: Eighteen pigs (DXS, n = 10; phosphate buffered saline [PBS], n = 8) underwent standard cardiopulmonary bypass. After aortic cross-clamping, cardiac arrest was initiated with modified Buckberg blood cardioplegia (BCP), repeated after 30 and 60 min with BCP containing either DXS (300 mg/10 ml, equivalent to 5 mg/kg) or 10 ml of PBS. Following 30 min reperfusion, pigs were weaned from CPB. During 2 h of observation, cardiac function was monitored by echocardiography and invasive pressure measurements. Inflammatory and coagulation markers were assessed regularly. Animals were then sacrificed and heart and lungs analyzed. Results: DXS significantly reduced CK-MB levels (43.4 ± 14.8 ng/ml PBS, 35.9 ± 11.1 ng/ml DXS, p = 0.042) and significantly diminished cytokine release: TNFalpha (1507.6 ± 269.2 pg/ml PBS, 222.1 ± 125.6 pg/ml DXS, p = 0.0071), IL1beta (1081.8 ± 203.0 pg/ml PBS, 110.7 ± 79.4 pg/ml DXS, p = 0.0071), IL-6 (173.0 ± 91.5 pg/ml PBS, 40.8 ± 19.4 pg/ml DXS, p = 0.002) and IL-8 (304.6 ± 81.3 pg/ml PBS, 25.4 ± 14.2 pg/ml DXS, p = 0.0071). Tissue endothelin-1 levels were significantly reduced (6.29 ± 1.90 pg/100 mg PBS, 3.55 ± 1.15 pg/100 mg DXS p = 0.030) as well as thrombin–anti-thrombin formation (20.7 ± 1.0 µg/ml PBS, 12.8 ± 4.1 µg/ml DXS, p = 0.043). Also DXS reduced cardiac and pulmonary complement deposition, neutrophil infiltration, hemorrhage and pulmonary edema (measured as lung water content, 81 ± 3% vs 78 ± 3%, p = 0.047), indicative of attenuated myocardial and pulmonary CPB-injury. Diastolic left ventricular function (measured as dp/dt min), pulmonary artery pressure (21 ± 3 mmHg PBS, 19 ± 3 mmHg DXS, p = 0.002) and right ventricular pressure (21 ± 1 mmHg PBS, 19 ± 3 mmHg DXS p = 0.021) were significantly improved with the use of DXS. Conclusions: Addition of DXS to the BCP solution ameliorates post-CPB injury and to a certain extent improves cardiopulmonary function. Endothelial protection in addition to myocyte protection may improve post-CPB outcome and recovery.

Key Words: Ischemia • Reperfusion • Complement inhibition • Cytoprotection • Endothelium




This article has been cited by other articles:


Home page
PerfusionHome page
E Hirleman and D. Larson
Cardiopulmonary bypass and edema: physiology and pathophysiology
Perfusion, November 1, 2008; 23(6): 311 - 322.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.